Erie, Pa.-based AHN Saint Vincent has purchased a former Rite Aid pharmacy property for $1.65 million, according to a May 4 report from the Erie Times-News. The property has been vacant since June, when Rite Aid closed its pharmacies in…

Pharmacy procurement has never been more complex — and the tools most organizations rely on haven’t kept up. At a featured session during Becker’s Spring Chief Pharmacy Officer Summit, pharmacy leaders and a technology expert examined what it takes to…

Rep. Tim Kennedy, D-N.Y., has secured $338,000 in federal funding to expand drug compounding capacity in Western New York. The investment will support development of a secure, regulated space at Buffalo, N.Y.-based D’Youville University’s School of Pharmacy for sterile and…

The FDA has approved an expanded use for Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) to treat agitation associated with dementia due to Alzheimer’s disease in adults. Auvelity is the first FDA-approved treatment for this condition that is not an antipsychotic,…

Pharmacy leaders are rethinking what it means to be “compliant” — and, increasingly, what it doesn’t. During a panel at Becker’s Spring Chief Pharmacy Officer Summit, leaders from multiple health systems described a shift away from treating compliance as a…

Mark Cuban has spent more than five years building something the healthcare industry is still figuring out how to respond to.  What started as a mail-order pharmacy selling generic drugs at transparent prices has grown into a sprawling operation spanning…

Based on what I’ve seen, nursing leaders today are often navigating a perfect storm: persistent workforce shortages, rising patient acuity, and mounting administrative burden2. While these challenges are complex, one truth is increasingly clear to me—if we want to give…

A federal judge has struck down North Dakota’s 340B drug pricing law, ruling it unconstitutional and permanently blocking its enforcement. U.S. District Judge Daniel Traynor found the law violated both the Supremacy Clause and the Commerce Clause by interfering with…

Pharmacy leaders say the future of the profession will not hinge on any single technology or policy change, but on whether the workforce, financial model and care delivery structure evolve fast enough to keep up. During a panel at Becker’s…

U.S. prescription drug spending increased 12.7% to $915.2 billion in 2025 and is projected to exceed $1 trillion in 2026, continuing to outpace other countries and drive healthcare costs higher, according to an April 29 report from the American Society…